Clinical Trial Update: Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial of PTK787 with pemetrexed, with or without cisplatin, for non-small cell lung cancer and pleural mesothelioma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pleural Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• PTK787 (Vatalanib)
• Platinol (cisplatin)

Snippet

Sponsor: Nevada Cancer Institute | Conditions: Non-Small Cell Lung Cancer and Pleural Mesothelioma | Phase 1, Phase 2 | Status: TERMINATED